Based on the press release, it is clear that a settlement agreement has been reached in the derivative matters involving ...

In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with ...

TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.17 which represents a slight increase of $1.28 or 1.32% from the prior close of $96.89. The stock opened at $97.03 and ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...

Capital Investment Advisors LLC raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 12.2% in ...

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...

International Assets Investment Management LLC lowered its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 95.3 ...

In a report released on January 6, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Boston Scientific (BSX – Research Report), ...

The research team at RBC Capital Markets published their top 30 global stock ideas for 2025, ...

Steven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was ...